Health

GSK's Lung Cancer Data Update

Updated 2026-09-14 13:40 UTC 1 source Neutral

GSK has released late-stage results for its LSD treatment, which showed promising outcomes. However, AstraZeneca’s breast cancer drug failed a key trial.

Coverage timeline — 1 article

STAT News

STAT+: GSK touts lung cancer data from two drugs

Late-stage results for Definium's LSD treatment, AstraZeneca breast cancer drug fails key trial, and more biotech news from The Readout

2026-09-14 13:34 UTC